Date Filed | Type | Description |
06/12/2023 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Light & Wonder, Inc.
Txns:
| Exercised 2,093 restricted stock units
@ $0 Exercised 1,928 restricted stock units
@ $0 |
|
06/09/2023 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Light & Wonder, Inc.
Txns:
| Granted 3,320 restricted stock units
@ $0 Exercised 3,840 restricted stock units
@ $0 |
|
09/06/2022 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Core Scientific, Inc./tx
Txns:
| Granted 400,038 shares
@ $0 |
|
06/21/2022 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc |
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2022 |
3
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 3 on Core Scientific, Inc./tx |
12/07/2021 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on TPG Pace Solutions Corp.
Txns:
| Disposed/sold 40,000 options to buy
@ $0 |
|
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/10/2020 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Sold 38,300 shares
@ $0.1316, valued at
$5k
|
|
10/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/12/2020 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on SCIENTIFIC GAMES CORP
Txns:
| Granted 8,372 restricted stock units
@ $0 Exercised 1,927 restricted stock units
@ $0 |
|
05/15/2020 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Paid exercise price by delivering 8,729 shares
@ $2.96, valued at
$25.8k
|
|
11/22/2019 |
4
| YOUNGBLOOD DR KNEELAND (Former Director) has filed a Form 4 on Accel Entertainment, Inc.
Txns:
| Sold 40,000 options to buy
@ $10.22, valued at
$408.8k
|
|
06/12/2019 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on SCIENTIFIC GAMES CORP
Txns:
| Granted 7,710 restricted stock units
@ $0 |
|
05/17/2019 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Paid exercise price by delivering 8,527 shares
@ $15.21, valued at
$129.7k
Granted 19,396 shares
@ $0 |
|
08/08/2018 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on SCIENTIFIC GAMES CORP
Txns:
| Granted 10,000 options to buy
@ $37.35, valued at
$373.5k
|
|
08/07/2018 |
3
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 3 on SCIENTIFIC GAMES CORP |
05/18/2018 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Granted 18,947 shares
@ $0 |
|
03/13/2018 |
3
| YOUNGBLOOD DR KNEELAND (CEO) has filed a Form 3 on Pharos Capital BDC, Inc. |
03/05/2018 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Paid exercise price by delivering 2,576 shares
@ $15.68, valued at
$40.4k
|
|
11/30/2017 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Bought 4,560 shares
@ $21.94, valued at
$100k
|
|
10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2017 |
3
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 3 on TPG Pace Holdings Corp. |
03/14/2017 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Pace Holdings Corp. |
03/03/2017 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc |
10/04/2016 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc |
07/25/2016 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc |
03/18/2016 |
4
| YOUNGBLOOD DR KNEELAND (Director) has filed a Form 4 on Mallinckrodt plc
Txns:
| Granted 4,041 shares
@ $0 Paid exercise price by delivering 458 shares
@ $55.69, valued at
$25.5k
|
|
12/03/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|